WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization ...

The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and ...

WuXi AppTec Co., Ltd. provides an integrated ... The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services.

EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of n ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been included in the S&P Global Sustainability ...

China’s telecom giants surge on NYSE reversal, WuXi slides as insider sells Hong Kong and China stocks gained as Chinese telecom giants surged after the New York Stock Exchange scraps its ...

WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...

EffiXTM is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a ...